← All trials
NCT00000504
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 1982
- Primary completion
- —
- Completion date
- Sep 1, 1985
- First posted
- —
- Last posted
- —
- Enrollment
- —
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- National Heart, Lung, and Blood Institute (NHLBI)Lead sponsor
- Baylor UniversityOfficial
- University of RochesterOfficial
- Columbia UniversityOfficial
- Rhode Island HospitalOfficial
- Johns Hopkins UniversityOfficial
- University of MontrealOfficial
- Salt Lake Clinic Research FoundationOfficial
- Medical College of VirginiaOfficial
- Vanderbilt UniversityOfficial
- Department of Veteran AffairsOfficial
- Clinical Data, Inc.Official
- University of Alabama, BirminghamOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.